Market Overview

Sanofi Q3 2012 - Interview with CFO Jérôme Contamine


Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2012. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Click to watch the video:

Topics covered in the interview include:

- Q3 2012 Results
- Diabetes
- Multiple Sclerosis
- Rare Diseases
- Vaccines
- Austerity in Europe
- Emerging Markets
- R&D pipeline

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website:

Investor Relations:
Sébastien Martel, +33 1 53 77 45 45
Media Relations:
+33 1 53 77 45 02

View Comments and Join the Discussion!